Sian Bigora, Chief Development Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 2,107 shares at $2.54 ($5K) on 2026-03-31, disclosed to the SEC on 2026-04-01.
Open-market purchase of $5k PCSA by Chief Development Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PCSA | BUY | 2026-04-17 | $5K | — | Filing → |